Delivery Order SPE2DB20D7066-SPE2DB25FC4QR
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram formulation, with a ceiling value of $3,251.10 under firm fixed pricing. This non-set-aside competitive award represents a child contract delivery order with an ultimate completion date of September 5, 2025, and is performed out of the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Proctofoam-HC 1%-1% foam in a 10-gram unit, with a ceiling value of $1,048.10. This competitively awarded contract uses firm fixed pricing and is classified as a non-set-aside procurement. The delivery order is expected to be completed by August 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,327.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units, with a ceiling value of $2,029.18. This is a firm fixed price, non-set-aside contract with a completion date of August 29, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting the Defense Logistics...
- The Defense Logistics Agency awarded a $1,257.60 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram quantities. This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen Drug Corp's existing relationship with...
- The Defense Logistics Agency awarded a $1,257.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam (10gm) on August 13, 2025, with an ultimate completion date of August 14, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit, valued at $1,060.08 under a firm fixed price contract. This delivery order represents a non-set-aside award issued to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The award serves military and federal healthcare supply needs through DLA's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,022.16 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam (10gm) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a $1,506.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a non-set-aside competitive award with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 9, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling...
- The Defense Logistics Agency awarded a delivery order valued at $2,031.24 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This non-competitive delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and carries firm fixed pricing. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution center for federal...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4QRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit, with a ceiling value of $1,257.72. This firm fixed-price delivery order, which carries an ultimate completion date of September 9, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor vehicle that runs through December 2026 and supports military healthcare systems globally. This award exemplifies AmerisourceBergen's ongoing role as a critical federal medical supply vendor, providing specialized pharmaceutical products to support Defense Health Agency and military healthcare requirements. Proctofoam-HC is a rectal foam product used for hemorrhoid and anal fissure treatment, reflecting the company's broad portfolio of pharmaceutical commodities spanning specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The firm's consistent receipt of competitively awarded delivery orders through the DLA medical supply chain demonstrates its capability to efficiently fulfill federal procurement requirements for diverse healthcare commodities at varying order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/8/25 |